T1	Participants 137 172	patients undergoing cardiac surgery
T2	Participants 1045 1147	patients who achieved hemostasis at the primary treatment site within 5 min, and maintained hemostasis
T3	Participants 1760 1809	hemostasis in patients undergoing cardiac surgery
